FLUZONE QUADRIVALENT

This brand name is authorized in Canada

Active ingredients

The drug FLUZONE QUADRIVALENT contains a combination of these active pharmaceutical ingredients (APIs):

1 Influenza, inactivated, surface antigen
UNII K8A11W1ZVV - INFLUENZA A VIRUS A/GUANGDONG-MAONAN/SWL1536/2019 CNIC-1909 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED)
Read about Influenza, inactivated, surface antigen
2 Influenza, inactivated, surface antigen
UNII 2828WNW8HO - INFLUENZA A VIRUS A/HONG KONG/2671/2019 (H3N2) NIB-121 NEURAMINIDASE ANTIGEN (UV, FORMALDEHYDE INACTIVATED)
Read about Influenza, inactivated, surface antigen
3 Influenza, inactivated, surface antigen
UNII B93BQX9789 - INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED)
Read about Influenza, inactivated, surface antigen
4 Influenza, inactivated, surface antigen
UNII 0LS66T074T - INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (UV, FORMALDEHYDE INACTIVATED)
Read about Influenza, inactivated, surface antigen

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
J07BB02 Influenza, purified antigen J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BB Influenza vaccines
Discover more medicines within J07BB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: CA Health Products and Food Branch Identifier(s): 02420643, 02432730

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.